Financhill
Sell
29

MASI Quote, Financials, Valuation and Earnings

Last price:
$178.60
Seasonality move :
4.36%
Day range:
$177.80 - $178.65
52-week range:
$125.94 - $179.00
Dividend yield:
0%
P/E ratio:
116.80x
P/S ratio:
6.32x
P/B ratio:
12.97x
Volume:
1M
Avg. volume:
1.9M
1-year change:
4.15%
Market cap:
$9.4B
Revenue:
$1.5B
EPS (TTM):
-$2.77

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MASI
Masimo Corp.
$392M $1.35 5.38% 565.51% $177.00
ANGO
AngioDynamics, Inc.
$76.8M -$0.11 6.62% -1.95% $19.33
BSX
Boston Scientific Corp.
$5.2B $0.79 11.18% 75.33% $100.81
ISRG
Intuitive Surgical, Inc.
$2.6B $2.13 16.31% 10.98% $605.08
PODD
Insulet Corp.
$729.9M $1.20 28.28% 138.1% $351.43
TFX
Teleflex, Inc.
$537.4M $1.22 -23.22% -41.31% $130.22
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MASI
Masimo Corp.
$178.59 $177.00 $9.4B 116.80x $0.00 0% 6.32x
ANGO
AngioDynamics, Inc.
$10.31 $19.33 $366.9M -- $0.00 0% 1.19x
BSX
Boston Scientific Corp.
$62.82 $100.81 $94.5B 32.82x $0.00 0% 4.74x
ISRG
Intuitive Surgical, Inc.
$452.07 $605.08 $156.3B 55.87x $0.00 0% 15.86x
PODD
Insulet Corp.
$204.31 $351.43 $14.2B 57.60x $0.00 0% 5.33x
TFX
Teleflex, Inc.
$117.81 $130.22 $5.2B 25.75x $0.34 1.16% 1.77x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MASI
Masimo Corp.
43.68% -0.398 8.01% 1.16x
ANGO
AngioDynamics, Inc.
6.27% 0.409 2.29% 1.22x
BSX
Boston Scientific Corp.
33.07% 1.671 8.45% 0.94x
ISRG
Intuitive Surgical, Inc.
0.95% 0.639 0.08% 3.73x
PODD
Insulet Corp.
39.8% 2.432 5.01% 1.82x
TFX
Teleflex, Inc.
46.59% -0.912 50.54% 0.97x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MASI
Masimo Corp.
$247.3M $83.9M 13.31% 22.71% 20.34% $51.9M
ANGO
AngioDynamics, Inc.
$42.1M -$2.5M -14.66% -15.21% -3.14% $3M
BSX
Boston Scientific Corp.
$3.6B $1.2B 8.3% 12.55% 22.93% $1B
ISRG
Intuitive Surgical, Inc.
$1.9B $864.3M 16.53% 16.59% 30.16% $730M
PODD
Insulet Corp.
$570.3M $146.3M 9.17% 17.89% 18.67% $33.9M
TFX
Teleflex, Inc.
$309.3M $38.2M -3.16% -4.98% 6.72% $151.6M

Masimo Corp. vs. Competitors

  • Which has Higher Returns MASI or ANGO?

    AngioDynamics, Inc. has a net margin of 15.01% compared to Masimo Corp.'s net margin of -7.99%. Masimo Corp.'s return on equity of 22.71% beat AngioDynamics, Inc.'s return on equity of -15.21%.

    Company Gross Margin Earnings Per Share Invested Capital
    MASI
    Masimo Corp.
    59.95% $1.31 $1.3B
    ANGO
    AngioDynamics, Inc.
    53.05% -$0.15 $188.1M
  • What do Analysts Say About MASI or ANGO?

    Masimo Corp. has a consensus price target of $177.00, signalling downside risk potential of -0.89%. On the other hand AngioDynamics, Inc. has an analysts' consensus of $19.33 which suggests that it could grow by 87.52%. Given that AngioDynamics, Inc. has higher upside potential than Masimo Corp., analysts believe AngioDynamics, Inc. is more attractive than Masimo Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    MASI
    Masimo Corp.
    0 8 0
    ANGO
    AngioDynamics, Inc.
    3 0 0
  • Is MASI or ANGO More Risky?

    Masimo Corp. has a beta of 1.203, which suggesting that the stock is 20.285% more volatile than S&P 500. In comparison AngioDynamics, Inc. has a beta of 0.435, suggesting its less volatile than the S&P 500 by 56.502%.

  • Which is a Better Dividend Stock MASI or ANGO?

    Masimo Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. AngioDynamics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Masimo Corp. pays -- of its earnings as a dividend. AngioDynamics, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MASI or ANGO?

    Masimo Corp. quarterly revenues are $412.5M, which are larger than AngioDynamics, Inc. quarterly revenues of $79.4M. Masimo Corp.'s net income of $61.9M is higher than AngioDynamics, Inc.'s net income of -$6.4M. Notably, Masimo Corp.'s price-to-earnings ratio is 116.80x while AngioDynamics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Masimo Corp. is 6.32x versus 1.19x for AngioDynamics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MASI
    Masimo Corp.
    6.32x 116.80x $412.5M $61.9M
    ANGO
    AngioDynamics, Inc.
    1.19x -- $79.4M -$6.4M
  • Which has Higher Returns MASI or BSX?

    Boston Scientific Corp. has a net margin of 15.01% compared to Masimo Corp.'s net margin of 12.68%. Masimo Corp.'s return on equity of 22.71% beat Boston Scientific Corp.'s return on equity of 12.55%.

    Company Gross Margin Earnings Per Share Invested Capital
    MASI
    Masimo Corp.
    59.95% $1.31 $1.3B
    BSX
    Boston Scientific Corp.
    68.5% $0.45 $36.4B
  • What do Analysts Say About MASI or BSX?

    Masimo Corp. has a consensus price target of $177.00, signalling downside risk potential of -0.89%. On the other hand Boston Scientific Corp. has an analysts' consensus of $100.81 which suggests that it could grow by 60.48%. Given that Boston Scientific Corp. has higher upside potential than Masimo Corp., analysts believe Boston Scientific Corp. is more attractive than Masimo Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    MASI
    Masimo Corp.
    0 8 0
    BSX
    Boston Scientific Corp.
    24 0 0
  • Is MASI or BSX More Risky?

    Masimo Corp. has a beta of 1.203, which suggesting that the stock is 20.285% more volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.781, suggesting its less volatile than the S&P 500 by 21.926%.

  • Which is a Better Dividend Stock MASI or BSX?

    Masimo Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Masimo Corp. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MASI or BSX?

    Masimo Corp. quarterly revenues are $412.5M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. Masimo Corp.'s net income of $61.9M is lower than Boston Scientific Corp.'s net income of $670M. Notably, Masimo Corp.'s price-to-earnings ratio is 116.80x while Boston Scientific Corp.'s PE ratio is 32.82x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Masimo Corp. is 6.32x versus 4.74x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MASI
    Masimo Corp.
    6.32x 116.80x $412.5M $61.9M
    BSX
    Boston Scientific Corp.
    4.74x 32.82x $5.3B $670M
  • Which has Higher Returns MASI or ISRG?

    Intuitive Surgical, Inc. has a net margin of 15.01% compared to Masimo Corp.'s net margin of 27.89%. Masimo Corp.'s return on equity of 22.71% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.

    Company Gross Margin Earnings Per Share Invested Capital
    MASI
    Masimo Corp.
    59.95% $1.31 $1.3B
    ISRG
    Intuitive Surgical, Inc.
    66.41% $2.21 $18.1B
  • What do Analysts Say About MASI or ISRG?

    Masimo Corp. has a consensus price target of $177.00, signalling downside risk potential of -0.89%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $605.08 which suggests that it could grow by 33.85%. Given that Intuitive Surgical, Inc. has higher upside potential than Masimo Corp., analysts believe Intuitive Surgical, Inc. is more attractive than Masimo Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    MASI
    Masimo Corp.
    0 8 0
    ISRG
    Intuitive Surgical, Inc.
    17 9 1
  • Is MASI or ISRG More Risky?

    Masimo Corp. has a beta of 1.203, which suggesting that the stock is 20.285% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.677, suggesting its more volatile than the S&P 500 by 67.7%.

  • Which is a Better Dividend Stock MASI or ISRG?

    Masimo Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Masimo Corp. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MASI or ISRG?

    Masimo Corp. quarterly revenues are $412.5M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. Masimo Corp.'s net income of $61.9M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, Masimo Corp.'s price-to-earnings ratio is 116.80x while Intuitive Surgical, Inc.'s PE ratio is 55.87x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Masimo Corp. is 6.32x versus 15.86x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MASI
    Masimo Corp.
    6.32x 116.80x $412.5M $61.9M
    ISRG
    Intuitive Surgical, Inc.
    15.86x 55.87x $2.9B $799.5M
  • Which has Higher Returns MASI or PODD?

    Insulet Corp. has a net margin of 15.01% compared to Masimo Corp.'s net margin of 12.96%. Masimo Corp.'s return on equity of 22.71% beat Insulet Corp.'s return on equity of 17.89%.

    Company Gross Margin Earnings Per Share Invested Capital
    MASI
    Masimo Corp.
    59.95% $1.31 $1.3B
    PODD
    Insulet Corp.
    72.76% $1.44 $2.5B
  • What do Analysts Say About MASI or PODD?

    Masimo Corp. has a consensus price target of $177.00, signalling downside risk potential of -0.89%. On the other hand Insulet Corp. has an analysts' consensus of $351.43 which suggests that it could grow by 72.01%. Given that Insulet Corp. has higher upside potential than Masimo Corp., analysts believe Insulet Corp. is more attractive than Masimo Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    MASI
    Masimo Corp.
    0 8 0
    PODD
    Insulet Corp.
    17 1 0
  • Is MASI or PODD More Risky?

    Masimo Corp. has a beta of 1.203, which suggesting that the stock is 20.285% more volatile than S&P 500. In comparison Insulet Corp. has a beta of 1.470, suggesting its more volatile than the S&P 500 by 47.012%.

  • Which is a Better Dividend Stock MASI or PODD?

    Masimo Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Masimo Corp. pays -- of its earnings as a dividend. Insulet Corp. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MASI or PODD?

    Masimo Corp. quarterly revenues are $412.5M, which are smaller than Insulet Corp. quarterly revenues of $783.8M. Masimo Corp.'s net income of $61.9M is lower than Insulet Corp.'s net income of $101.6M. Notably, Masimo Corp.'s price-to-earnings ratio is 116.80x while Insulet Corp.'s PE ratio is 57.60x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Masimo Corp. is 6.32x versus 5.33x for Insulet Corp.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MASI
    Masimo Corp.
    6.32x 116.80x $412.5M $61.9M
    PODD
    Insulet Corp.
    5.33x 57.60x $783.8M $101.6M
  • Which has Higher Returns MASI or TFX?

    Teleflex, Inc. has a net margin of 15.01% compared to Masimo Corp.'s net margin of -0.62%. Masimo Corp.'s return on equity of 22.71% beat Teleflex, Inc.'s return on equity of -4.98%.

    Company Gross Margin Earnings Per Share Invested Capital
    MASI
    Masimo Corp.
    59.95% $1.31 $1.3B
    TFX
    Teleflex, Inc.
    54.37% -$16.15 $5.9B
  • What do Analysts Say About MASI or TFX?

    Masimo Corp. has a consensus price target of $177.00, signalling downside risk potential of -0.89%. On the other hand Teleflex, Inc. has an analysts' consensus of $130.22 which suggests that it could grow by 10.54%. Given that Teleflex, Inc. has higher upside potential than Masimo Corp., analysts believe Teleflex, Inc. is more attractive than Masimo Corp..

    Company Buy Ratings Hold Ratings Sell Ratings
    MASI
    Masimo Corp.
    0 8 0
    TFX
    Teleflex, Inc.
    0 8 0
  • Is MASI or TFX More Risky?

    Masimo Corp. has a beta of 1.203, which suggesting that the stock is 20.285% more volatile than S&P 500. In comparison Teleflex, Inc. has a beta of 0.837, suggesting its less volatile than the S&P 500 by 16.296%.

  • Which is a Better Dividend Stock MASI or TFX?

    Masimo Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Teleflex, Inc. offers a yield of 1.16% to investors and pays a quarterly dividend of $0.34 per share. Masimo Corp. pays -- of its earnings as a dividend. Teleflex, Inc. pays out 91.92% of its earnings as a dividend. Teleflex, Inc.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MASI or TFX?

    Masimo Corp. quarterly revenues are $412.5M, which are smaller than Teleflex, Inc. quarterly revenues of $569M. Masimo Corp.'s net income of $61.9M is higher than Teleflex, Inc.'s net income of -$3.6M. Notably, Masimo Corp.'s price-to-earnings ratio is 116.80x while Teleflex, Inc.'s PE ratio is 25.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Masimo Corp. is 6.32x versus 1.77x for Teleflex, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MASI
    Masimo Corp.
    6.32x 116.80x $412.5M $61.9M
    TFX
    Teleflex, Inc.
    1.77x 25.75x $569M -$3.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Sell
46
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 36x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 34x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 27x

Alerts

Buy
51
AAOI alert for Apr 3

Applied Optoelectronics, Inc. [AAOI] is up 20.3% over the past day.

Buy
59
SBAC alert for Apr 3

SBA Communications Corp. [SBAC] is up 18.96% over the past day.

Buy
55
VSAT alert for Apr 3

ViaSat, Inc. [VSAT] is up 18.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock